Amoxicillin-1A Pharma 750 mg tabletki powlekane Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

amoxicillin-1a pharma 750 mg tabletki powlekane

1a pharma gmbh - amoxicillinum - tabletki powlekane - 750 mg

Cabazitaxel Ever Pharma 10 mg/ml Koncentrat do sporządzania roztworu do infuzji Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

cabazitaxel ever pharma 10 mg/ml koncentrat do sporządzania roztworu do infuzji

ever valinject gmbh - cabazitaxelum - koncentrat do sporządzania roztworu do infuzji - 10 mg/ml

Vancomycin CNP Pharma 500 mg proszek do sporządzania roztworu do infuzji Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

vancomycin cnp pharma 500 mg proszek do sporządzania roztworu do infuzji

cnp pharma gmbh - vancomycini hydrochloridum - proszek do sporządzania roztworu do infuzji - 500 mg

Vancomycin CNP Pharma 1000 mg proszek do sporządzania roztworu do infuzji Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

vancomycin cnp pharma 1000 mg proszek do sporządzania roztworu do infuzji

cnp pharma gmbh - vancomycini hydrochloridum - proszek do sporządzania roztworu do infuzji - 1000 mg

CetAlergin 10 mg Tabletki powlekane Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

cetalergin 10 mg tabletki powlekane

pharmaswiss Česká republika s.r.o. - cetirizini dihydrochloridum - tabletki powlekane - 10 mg

Evusheld Európai Unió - lengyel - EMA (European Medicines Agency)

evusheld

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Comirnaty Európai Unió - lengyel - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.

Veklury Európai Unió - lengyel - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Treprovist 0,3 mg/ml Krople do oczu, roztwór Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

treprovist 0,3 mg/ml krople do oczu, roztwór

sandoz gmbh - bimatoprost - krople do oczu, roztwór - 0,3 mg/ml

Boviseal 2,6 g/4 g Zawiesina dowymieniowa Lengyelország - lengyel - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

boviseal 2,6 g/4 g zawiesina dowymieniowa

cross vetpharm group ltd. - bismuthi subnitras - zawiesina dowymieniowa - 2,6 g/4 g - bydło